CO-DEVELOPMENT OPTIONS (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Nov. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Co Development Options [Member] | |||||
| Capitalized contract costs, gross | $ 5,291,667 | ||||
| Capitalized contract costs, accumulated amortization | 3,987,500 | ||||
| Capitalized contract costs, net | 1,304,167 | ||||
| Consensi Product [Member] | Purple Bio Tech [Member] | |||||
| Convertible notes outstanding | $ 218,750 | $ 218,750 | |||
| CD38 Assets [Member] | |||||
| Long term note payable | $ 1,750,000 | ||||
| CD38 Assets [Member] | Vy Gen [Member] | |||||
| Payments to acquire intangible assets | 1,750,000 | ||||
| Long term note payable | 3,250,000 | ||||
| Repayment of debt | $ 1,500,000 | $ 250,000 | 1,500,000 | ||
| Capitalized contract costs, gross | $ 5,000,000 | ||||
| X | ||||||||||
- Definition Amount of accumulated amortization of asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of long-term notes classified as other, payable after one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|